1. Home
  2. MXC vs LPCN Comparison

MXC vs LPCN Comparison

Compare MXC & LPCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MXC

Mexco Energy Corporation

N/A

Current Price

$10.86

Market Cap

17.6M

Sector

Energy

ML Signal

N/A

Logo Lipocine Inc.

LPCN

Lipocine Inc.

N/A

Current Price

$2.27

Market Cap

20.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MXC
LPCN
Founded
1972
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
17.6M
20.0M
IPO Year
1995
2011

Fundamental Metrics

Financial Performance
Metric
MXC
LPCN
Price
$10.86
$2.27
Analyst Decision
Hold
Analyst Count
0
1
Target Price
N/A
N/A
AVG Volume (30 Days)
74.5K
27.8K
Earning Date
02-10-2026
05-07-2026
Dividend Yield
1.02%
N/A
EPS Growth
N/A
N/A
EPS
0.24
N/A
Revenue
$2,705,235.00
$1,976,677.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$92.00
P/E Ratio
$44.75
N/A
Revenue Growth
7.12
N/A
52 Week Low
$7.16
$1.81
52 Week High
$16.48
$12.37

Technical Indicators

Market Signals
Indicator
MXC
LPCN
Relative Strength Index (RSI) 64.46 53.45
Support Level $8.68 $2.16
Resistance Level $12.03 $2.30
Average True Range (ATR) 0.75 0.11
MACD 0.10 0.02
Stochastic Oscillator 82.42 48.77

Price Performance

Historical Comparison
MXC
LPCN

About MXC Mexco Energy Corporation

Mexco Energy Corporation is an independent oil and gas company. It is engaged in the acquisition, exploration, development, and production of natural gas and crude oil properties located in the United States. The company carried out its operation in the Permian Basin of West Texas. It is focusing on two primary areas, the Delaware Basin located in the Western portion of the Permian Basin including Lea and Eddy Counties, New Mexico and Loving County, Texas, and the Midland Basin located in the Eastern portion of the Permian Basin including Reagan, Upton, Midland, Martin, Howard, and Glasscock Counties, Texas. The company generates revenue from Oil sales, Natural gas sales, oil and gas royalty interests.

About LPCN Lipocine Inc.

Lipocine Inc is a clinical-stage biopharmaceutical company that is engaged in research and development for the delivery of drugs using its proprietary delivery technology. Its principal operation is to provide oral delivery solutions for existing drugs. Lipocine develops its drug candidates, or it develops drug candidates on behalf of or in collaboration with corporate partners. The company's product TLANDO is an oral testosterone replacement therapy (TRT). It also has other products in the pipeline, such as LPCN 1144, TLANDO, TLANDO XR, LPCN 1148, LPCN 1107, LPCN 1154, and LIP RAL7 Technology. The Company has a single reportable segment, research, and development for the delivery of drugs using its proprietary delivery technology.

Share on Social Networks: